SCHEMBL20436157

SCHEMBL20436157

C[C@H](COP(=O)([O-])OCC[N+](C)(C)C)OCCCCC(=O)O

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RECQL P46063 1/20 0.59
▸ SMN1; SMN2 Q16637 2/20 0.51
▸ PLA2G10 O15496 1/20 0.50
▸ MAPK1 P28482 4/20 0.49
▸ LMNA P02545 3/20 0.49
▸ MAPT P10636 3/20 0.49
▸ MEN1 O00255 2/20 0.49
▸ GMNN O75496 2/20 0.49
▸ BLM P54132 2/20 0.49
▸ KMT2A Q03164 2/20 0.49
▸ NPSR1 Q6W5P4 2/20 0.49
▸ TP53 P04637 2/20 0.49
▸ CYP3A4 P08684 2/20 0.49
▸ CYP2D6 P10635 2/20 0.49
▸ CYP2C9 P11712 2/20 0.49
▸ ALOX15 P16050 2/20 0.49
▸ NFKB1 P19838 2/20 0.49
▸ CYP2C19 P33261 2/20 0.49
▸ HIF1A Q16665 2/20 0.49
▸ MTOR P42345 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2602822 0.86 FABP3 (0.48) RECQLPLA2G10MAPK1LMNAMAPT
SCHEMBL21631754 0.84 LMNA (0.67) RECQLSMN1; SMN2PLA2G10LMNAMAPT
SCHEMBL2837952 0.82 RECQL (0.57) RECQLSMN1; SMN2PLA2G10MAPK1LMNA
SCHEMBL2232537 0.81 RECQL (0.66) RECQLSMN1; SMN2MAPK1LMNAMAPT
SCHEMBL2234409 0.81 RECQL (0.66) RECQLSMN1; SMN2MAPK1LMNAMAPT
SCHEMBL704034 0.81 RECQL (0.81) RECQLSMN1; SMN2MAPK1LMNAMAPT
SCHEMBL2232633 0.81 RECQL (0.81) RECQLSMN1; SMN2MAPK1LMNAMAPT
Vb-201 SCHEMBL2071110 0.81 RECQL (0.81) RECQLSMN1; SMN2MAPK1LMNAMAPT
SCHEMBL2232585 0.81 RECQL (0.81) RECQLSMN1; SMN2MAPK1LMNAMAPT
Vb-201 SCHEMBL14322398 0.81 RECQL (0.81) RECQLSMN1; SMN2MAPK1LMNAMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180214543-A1 Motile Sperm Domain Containing Protein 2 and Inflammation IMMUNEWALK THERAPEUTICS, INC. 2018-08-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180214543-A1 Motile Sperm Domain Containing Protein 2 and Inflammation NASP, CATSPER1, SPAG5 RECQL 1131/4885SMN1; SMN2 1548/4885PLA2G10 561/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback